Open AccessFerumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients
Author(s) -
Robert Provenzano,
Brigitte Schiller,
Madhumathi Rao,
Daniel W. Coyne,
Louis Brenner,
Brian J.G. Pereira
Publication year - 2009
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02840608
Subject(s) - medicine , ferumoxytol , hemodialysis , intravenous iron , renal replacement therapy , iron sucrose , intensive care medicine , surgery , radiology , anemia , magnetic resonance imaging , iron deficiency
Intravenous iron is a key component of anemia management for chronic kidney disease (CKD). Ferumoxytol is a unique intravenous iron product that can be administered as a rapid injection in doses up to 510 mg.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom